戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 MEN1, the tumor suppressor gene disrupted in multiple endocrine neoplasia type 1.
2 , as compared with none of the patients with multiple endocrine neoplasia type 1.
3 n the diverse nature of the benign tumors in multiple endocrine neoplasia type 1.
4 -Ellison syndrome or nonfunctional PETs with multiple endocrine neoplasia-type 1.
5                                 They include multiple endocrine neoplasia types 1 and 2, von Hippel L
6 missense mutations found in individuals with multiple endocrine neoplasia type 1, and the interacting
7  in patients with ZES, especially those with multiple endocrine neoplasia type 1, and the precise ord
8 uitary neoplasias: McCune-Albright syndrome, multiple endocrine neoplasia type 1, Carney complex and,
9 ith lymph node involvement and patients with multiple endocrine neoplasia type 1 did not demonstrate
10                                     Familial multiple endocrine neoplasia type 1 (FMEN1) is an autoso
11 product of the MEN1 gene mutated in familial multiple endocrine neoplasia type 1, has not been define
12 ar, the areas of gastrinoma, insulinoma, and multiple endocrine neoplasia type 1 have received carefu
13 from pituitary adenomas in two patients with multiple endocrine neoplasia type 1 in which cells with
14                                              Multiple endocrine neoplasia type 1 is a familial cancer
15                                              Multiple endocrine neoplasia type 1 is an autosomal domi
16                                     Familial multiple endocrine neoplasia type 1 is an autosomal domi
17 ect genetic evidence that MEN1, the gene for multiple endocrine neoplasia type 1, is a tumor suppress
18 ncing analysis, and deletion analysis of the multiple endocrine neoplasia type 1 locus succeeded in t
19 g in a large group of extended families with multiple endocrine neoplasia type 1 (MEN 1), with the ul
20 nts with sporadic ZES, but not in those with multiple endocrine neoplasia type 1 (MEN-1) and ZES, the
21  of heterozygosity (LOH) at the locus of the multiple endocrine neoplasia type 1 (MEN-1) gene was stu
22                                              Multiple endocrine neoplasia type 1 (MEN-1) may be assoc
23                                              Multiple endocrine neoplasia, type 1 (MEN I), is an auto
24 S were studied prospectively, with 39 having multiple endocrine neoplasia, type 1 (MEN-1) (high incre
25 even of 61 (11%) patients had a diagnosis of multiple endocrine neoplasia-type 1 (MEN-1).
26 previously identified at the locus linked to multiple endocrine neoplasia type 1 (MEN1) and as prespl
27            While mapping candidate genes for multiple endocrine neoplasia type 1 (MEN1) at 11q13, we
28                                              Multiple endocrine neoplasia type 1 (MEN1) consists of b
29                                Patients with multiple endocrine neoplasia type 1 (MEN1) develop multi
30                                              Multiple endocrine neoplasia type 1 (MEN1) is a dominant
31                                              Multiple endocrine neoplasia type 1 (MEN1) is a familial
32                                              Multiple endocrine neoplasia type 1 (MEN1) is a familial
33                                              Multiple endocrine neoplasia type 1 (MEN1) is an autosom
34                                              Multiple endocrine neoplasia type 1 (MEN1) is an autosom
35                                              Multiple endocrine neoplasia type 1 (MEN1) is an autosom
36                                              Multiple endocrine neoplasia type 1 (MEN1) is an autosom
37                                              Multiple endocrine neoplasia type 1 (MEN1) is an autosom
38                                              Multiple endocrine neoplasia type 1 (MEN1) is an inherit
39                                              Multiple endocrine neoplasia type 1 (MEN1) is an inherit
40                                              Multiple endocrine neoplasia type 1 (MEN1) is characteri
41                                              Multiple endocrine neoplasia type 1 (MEN1) is characteri
42         Primary hyperparathyroidism (HPT) in multiple endocrine neoplasia type 1 (MEN1) patients with
43 s occur both sporadically and as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome.
44 nscriptionally active chromatin, whereas the multiple endocrine neoplasia type 1 (MEN1) tumor suppres
45                    Menin, the product of the multiple endocrine neoplasia type 1 (Men1) tumor suppres
46                                              Multiple endocrine neoplasia type 1 (MEN1), an autosomal
47                                              Multiple endocrine neoplasia type 1 (MEN1), an inherited
48  they are especially common in patients with multiple endocrine neoplasia type 1 (MEN1), and most stu
49 gene, mutations in which are responsible for multiple endocrine neoplasia type 1 (MEN1), encodes a 61
50                                              Multiple endocrine neoplasia type 1 (MEN1), the heritabl
51 crine tumor susceptibility syndromes such as multiple endocrine neoplasia type 1 (MEN1), von Hippel L
52 ppressor gene that is mutated in humans with multiple endocrine neoplasia type 1 (MEN1).
53 t is mutated in the inherited tumor syndrome multiple endocrine neoplasia type 1 (MEN1).
54 n patients with an inherited tumor syndrome, multiple endocrine neoplasia type 1 (MEN1).
55 that occur sporadically and in patients with multiple endocrine neoplasia type 1 (MEN1).
56  sporadically and rarely in association with multiple endocrine neoplasia type 1 (MEN1).
57 mas can develop sporadically or as a part of multiple endocrine neoplasia type 1 (MEN1).
58  Gastrinomas and insulinomas are frequent in multiple endocrine neoplasia type 1 (MEN1).
59 s are caused by inherited syndromes, such as multiple endocrine neoplasia type 1 (MEN1).
60 duodenum occur sporadically and as a part of multiple endocrine neoplasia type 1 (MEN1).
61 beta), T-type calcium channel (CACNA1G), and multiple endocrine neoplasia type-1 (MEN1) genes, and of
62 have shown that the gene responsible for the multiple endocrine neoplasia type-1 (MEN1) syndrome loca
63  targets of tumorigenesis in the syndrome of multiple endocrine neoplasia type-1 (MEN1).
64                       BACKGROUND & AIMS: The multiple endocrine neoplasia, type 1 (MEN1) locus encode
65                                              Multiple endocrine neoplasia-type 1 (MEN1) is an autosom
66 sm (FIHP), or as part of a syndrome, such as multiple endocrine neoplasia type 1 or hyperparathyroidi
67 e Zollinger-Ellison syndrome who do not have multiple endocrine neoplasia type 1 or metastatic diseas
68                         The genetic test for multiple endocrine neoplasia type 1 syndrome mutation wa
69  Eight patients had sporadic NETs, and 1 had multiple endocrine neoplasia type 1 syndrome.
70  the role of EUS screening for patients with multiple endocrine neoplasia type 1 syndrome.
71 ary hyperparathyroidism and one patient with multiple endocrine neoplasia type 1 syndrome.
72 nts, 123 had sporadic gastrinomas and 28 had multiple endocrine neoplasia type 1 with an imaged tumor

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。